UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Characterizing the Microstructure of Heparin and Heparan Sulfate Using N‑Sulfoglucosamine 1H and 15N NMR Chemical Shift Analysis

Analytical chemistry (Washington), 2013-01, Vol.85 (2), p.1247-1255

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficient selective deacetylation of complex oligosaccharides using the neutral organotin catalyst [tBu2SnOH(Cl)]2

Carbohydrate research, 2020-12, Vol.498, p.108172-108172, Article 108172

2020

Link zum Volltext

Verfügbarkeit prüfen

Prevention of Triglyceridemia by (Non-)Anticoagulant Heparin(oids) Does Not Preclude Transplant Vasculopathy and Glomerulosclerosis: PO2054

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.629-629

2021

Link zum Volltext

Verfügbarkeit prüfen

High Resolution Mass Spectrometry for the Recognition and Structural Characterization of a New Antimicrobial Compound

Pharmacology & pharmacy, 2018, Vol.9 (5), p.135-148

2018

Link zum Volltext

Verfügbarkeit prüfen

PROFILING GLYCOL-SPLIT HEPARINS BY HPLC/MS ANALYSIS OF THEIR HEPARINASE-GENERATED OLIGOSACCHARIDES1

Analytical biochemistry, 2012-11, Vol.434 (1), p.112-122

2012

Link zum Volltext

Verfügbarkeit prüfen

Characterizing the Microstructure of Heparin and Heparan Sulfate Using N -Sulfoglucosamine 1 H and 15 N NMR Chemical Shift Analysis

Analytical chemistry (Washington), 2013-01, Vol.85 (2), p.1247-1255

2013

Link zum Volltext

Verfügbarkeit prüfen

Characterizing the Microstructure of Heparin and Heparan Sulfate Using N-Sulfoglucosamine ^sup 1^H and ^sup 15^N NMR Chemical Shift Analysis

Analytical chemistry (Washington), 2013-01, Vol.85 (2), p.1247

2013

Link zum Volltext

Verfügbarkeit prüfen

Hepcidin Inhibition by Modified Heparins without Anticoagulant Activity

Blood, 2012-11, Vol.120 (21), p.483-483

2012

Link zum Volltext

Verfügbarkeit prüfen

Reversed-phase ion-pair ultra-high-performance-liquid chromatography―mass spectrometry for fingerprinting low-molecular-weight heparins: State-of-the art of (UHP)LC-MS(-MS) techniques and their practical application

Journal of chromatography, 2013, Vol.1292, p.201-210

2013

Link zum Volltext

Verfügbarkeit prüfen

Heparin-derived heparan sulfate mimics that modulate inflammation and cancer

Matrix biology, 2010-04, Vol.29 (6), p.442-452

2010

Link zum Volltext

Verfügbarkeit prüfen

Inhibitory effects of glycosaminoglycans on basal and stimulated transforming growth factor- 1 expression in mesangial cells: biochemical and structural considerations

Glycobiology (Oxford), 2011-08, Vol.21 (8), p.1029-1037

2011

Link zum Volltext

Verfügbarkeit prüfen

Anti-Heparanase Therapy in Combination with Conventional Chemotherapy Potently Inhibits Multiple Myeloma Growth in Vivo

Blood, 2008-11, Vol.112 (11), p.5165-5165

2008

Link zum Volltext

Verfügbarkeit prüfen

A Heparin-Based Inhibitor of Heparanase Blocks Myeloma Growth In Vivo by Targeting the Tumor Microenvironment

Blood, 2007-11, Vol.110 (11), p.1502-1502

2007

Link zum Volltext

Verfügbarkeit prüfen

Carbohydrate-Based Antithrombotics

Carbohydrate-Based Therapeutics, 2023

2023

Link zum Volltext

Verfügbarkeit prüfen

The Heparanase Inhibitor SST0001 Is a Potent Inhibitor of Myeloma Growth In Vivo

Blood, 2008-11, Vol.112 (11), p.246-246

2008

Link zum Volltext

Verfügbarkeit prüfen

Interactions of low-molecular-weight semi-synthetic sulfated heparins with human leukocyte elastase and human cathepsin G

Biochemical pharmacology, 2005, Vol.71 (3), p.287-293

2005

Link zum Volltext

Verfügbarkeit prüfen

Generation of anti-factor Xa active, 3- O-sulfated glucosamine-rich sequences by controlled desulfation of oversulfated heparins

Carbohydrate research, 2001-12, Vol.336 (4), p.283-290

2001

Link zum Volltext

Verfügbarkeit prüfen

Chemical derivatization as a strategy to study structure-activity relationships of glycosaminoglycans: Glycosaminoglycans: Anticoagulant and Nonanticoagulant Actions

Seminars in thrombosis and hemostasis, 2002, Vol.28 (4), p.335-342

2002

Link zum Volltext

Verfügbarkeit prüfen

Inhibitory effects of glycosaminoglycans on basal and stimulated transforming growth factor-β1 expression in mesangial cells: biochemical and structural considerations

Glycobiology (Oxford), 2011-08, Vol.21 (8), p.1029-1037

2011

Link zum Volltext

Verfügbarkeit prüfen

Modulation of antithrombin-protease interactions by semisynthetic low-molecular-weight heparins with different sulfation patterns: Pediatric Thrombosis and Hemostasis: Maureen Andrew Memorial Issue, Part 2

Seminars in thrombosis and hemostasis, 2003, Vol.29 (6), p.661-670

2003

Link zum Volltext

Verfügbarkeit prüfen

MALDI mass spectrometry as a tool for characterizing glycosaminoglycan oligosaccharides and their interaction with proteins: Glycoaminoglycans

Seminars in thrombosis and hemostasis, 2001, Vol.27 (5), p.465-472

2001

Link zum Volltext

Verfügbarkeit prüfen

Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5

Carbohydrate research, 1994-10, Vol.263 (2), p.271-284

1994

Link zum Volltext

Verfügbarkeit prüfen

Effects of calcium ions on the interactions between antithrombin and factor Xa mediated by variously sulfated, semisynthetic low-molecular-weight heparins: Glycosaminoglycans: Anticoagulant and Nonanticoagulant Actions

Seminars in thrombosis and hemostasis, 2002, Vol.28 (4), p.355-359

2002

Link zum Volltext

Verfügbarkeit prüfen

Generation of “Neoheparin” from E. c oli K5 Capsular Polysaccharide

Journal of medicinal chemistry, 2005-01, Vol.48 (2), p.349-352

2005

Link zum Volltext

Verfügbarkeit prüfen

Professor Casu and Cyclodextrins

The History of Cyclodextrins, 2020, Vol.52, p.157-179

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(35)
Buchkapitel
(4)

Sprache

Englisch
(39)
Japanisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Characterizing the Microstructure of Heparin and Heparan Sulfate Using N‑Sulfoglucosamine 1H and 15N NMR Chemical Shift Analysis

Efficient selective deacetylation of complex oligosaccharides using the neutral organotin catalyst [tBu2SnOH(Cl)]2

Prevention of Triglyceridemia by (Non-)Anticoagulant Heparin(oids) Does Not Preclude Transplant Vasculopathy and Glomerulosclerosis: PO2054

High Resolution Mass Spectrometry for the Recognition and Structural Characterization of a New Antimicrobial Compound

PROFILING GLYCOL-SPLIT HEPARINS BY HPLC/MS ANALYSIS OF THEIR HEPARINASE-GENERATED OLIGOSACCHARIDES1

Characterizing the Microstructure of Heparin and Heparan Sulfate Using N -Sulfoglucosamine 1 H and 15 N NMR Chemical Shift Analysis

Characterizing the Microstructure of Heparin and Heparan Sulfate Using N-Sulfoglucosamine ^sup 1^H and ^sup 15^N NMR Chemical Shift Analysis

Hepcidin Inhibition by Modified Heparins without Anticoagulant Activity

Reversed-phase ion-pair ultra-high-performance-liquid chromatography―mass spectrometry for fingerprinting low-molecular-weight heparins: State-of-the art of (UHP)LC-MS(-MS) techniques and their practical application

Heparin-derived heparan sulfate mimics that modulate inflammation and cancer

Inhibitory effects of glycosaminoglycans on basal and stimulated transforming growth factor- 1 expression in mesangial cells: biochemical and structural considerations

Anti-Heparanase Therapy in Combination with Conventional Chemotherapy Potently Inhibits Multiple Myeloma Growth in Vivo

A Heparin-Based Inhibitor of Heparanase Blocks Myeloma Growth In Vivo by Targeting the Tumor Microenvironment

Carbohydrate-Based Antithrombotics

The Heparanase Inhibitor SST0001 Is a Potent Inhibitor of Myeloma Growth In Vivo

Interactions of low-molecular-weight semi-synthetic sulfated heparins with human leukocyte elastase and human cathepsin G

Generation of anti-factor Xa active, 3- O-sulfated glucosamine-rich sequences by controlled desulfation of oversulfated heparins

Chemical derivatization as a strategy to study structure-activity relationships of glycosaminoglycans: Glycosaminoglycans: Anticoagulant and Nonanticoagulant Actions

Inhibitory effects of glycosaminoglycans on basal and stimulated transforming growth factor-β1 expression in mesangial cells: biochemical and structural considerations

Modulation of antithrombin-protease interactions by semisynthetic low-molecular-weight heparins with different sulfation patterns: Pediatric Thrombosis and Hemostasis: Maureen Andrew Memorial Issue, Part 2

MALDI mass spectrometry as a tool for characterizing glycosaminoglycan oligosaccharides and their interaction with proteins: Glycoaminoglycans

Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5

Effects of calcium ions on the interactions between antithrombin and factor Xa mediated by variously sulfated, semisynthetic low-molecular-weight heparins: Glycosaminoglycans: Anticoagulant and Nonanticoagulant Actions

Generation of “Neoheparin” from E. c oli K5 Capsular Polysaccharide

Professor Casu and Cyclodextrins

Aktive Filter

Suchergebnisse filtern